Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Grass pollen allergy vaccine tablet - ALK-Abello

Next Previous
Drug Profile

Grass pollen allergy vaccine tablet - ALK-Abello

Alternative Names: ALK Tablet; Grass AIT; Grass pollen allergy therapy - ALK-Abello; Grastek; Grazax; Grazax-R; MK-7243; P.-pratense-allergy-immunotherapy-ALK-Abello; P.-pratense-extract-ALK-Abello; P.-pratense-pollen-extract-ALK-Abello; Phelum-pratense-extract-ALK-Abello; Phleum pratense pollen extract; Phleum-pratense-allegy-immunotherapy-ALK-Abello; Phleum-pratense-pollen-extract-ALK-Abello; SCH-697243; Standardized-allergenic-extract-Timothy-grass; Timothy-grass-pollen-allergen-extract-(Grazax); Timothy-grass-pollen-allergy-immunotherapy-ALK-Abello; Timothy-grass-pollen-allergy-therapy-ALK-Abello; Timothy-grass-pollen-allergy-vaccine-ALK-Abello; Timothy-grass-sublingual-tablet-standardized-allergenic-extract

Latest Information Update: 14 Dec 2023

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator ALK-Abello
  • Developer Abbott Laboratories; ALK-Abello; Merck & Co; Seqirus
  • Class Allergens; Antiallergics; Plant allergy immunotherapies
  • Mechanism of Action Immunomodulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Seasonal allergic rhinitis
  • Phase III Allergic asthma

Most Recent Events

  • 13 Dec 2023 ALK and Torii Pharmaceuticals agree to co-develop Grass pollen allergy vaccine tablet for Seasonal allergic rhinitis
  • 16 Apr 2021 Discontinued - Preregistration for Seasonal allergic rhinitis in Russia (Sublingual)
  • 07 Jul 2017 Launched for Seasonal allergic rhinitis in Australia (Sublingual)
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Legal
Back to top